ASHLEY WARD: Open Payments
NPI 1841738606 · BARRINGTON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$707 in 29 payments from 10 companies in 2025. Trend: 2023 $936 · 2024 $799 · 2025 $707
Food & beverage: $707
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $221 |
| Optinose US, Inc. | 5 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $83 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| Regeneron Healthcare Solutions, Inc. | 3 | $57 |
| ALK-Abello, Inc | 2 | $45 |
| Paratek Pharmaceuticals, Inc. | 2 | $40 |
| Blueprint Medicines Corporation | 1 | $30 |
| Stryker Corporation | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $28 |
Products named: DUPIXENT, Xhance, CUVITRU, AYVAKIT, Odactra, TEZSPIRE, SCOPIS ENT, NUCALA.
Industry payments across IL — which companies pay providers there.
